Previous Article | Next Article ![]()
Molecular and Cellular Biology, January 1999, p. 12-20, Vol. 19, No. 1
Programs in Molecular and Cellular Biology
and Lung Biology, Department of Pathology, Tulane Cancer Center and
Tulane/Xavier Center for Bioenvironmental Research, New Orleans,
Louisiana 70112
Received 18 June 1998/Returned for modification 29 July
1998/Accepted 18 September 1998
The proliferating cell nuclear antigen (PCNA) is a highly conserved
cellular protein that functions both in DNA replication and in DNA
repair. Exposure of a rat embryo fibroblast cell line (CREF cells) to
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
p53-Mediated Regulation of Proliferating Cell
Nuclear Antigen Expression in Cells Exposed to Ionizing
Radiation
and
radiation induced simultaneous expression of PCNA with the p53
tumor suppressor protein and the cyclin-dependent kinase inhibitor
p21WAF1/Cip1. PCNA mRNA levels transiently increased in
serum-starved cells exposed to ionizing radiation, an observation
suggesting that the radiation-associated increase in PCNA expression
could be dissociated from cell cycle progression. Irradiation of CREF
cells activated a transiently expressed PCNA promoter chloramphenicol acetyltransferase construct through p53 binding sequences via a
mechanism blocked by a dominant negative mutant p53. Electrophoretic mobility shift assays with nuclear extracts prepared from irradiated CREF cells produced four p53-specific DNA-protein complexes with the
PCNA p53 binding site. Addition of monoclonal antibody PAb421 (p53-specific) or AC238 (specific to the transcriptional coactivator p300/CREB binding protein) to the mobility shift assay distinguished different forms of p53 that changed in relative abundance with time
after irradiation. These findings suggest a complex cellular response
to DNA damage in which p53 transiently activates expression of PCNA for
the purpose of limited DNA repair. In a population of nongrowing cells
with diminished PCNA levels, this pathway may be crucial to survival
following DNA damage.
*
Corresponding author. Mailing address: Department of
Pathology, SL-79, Tulane University Medical Center, 1430 Tulane Ave., New Orleans, LA 70112. Phone: (504) 585-6953. Fax: (504) 588-5707. E-mail: gmorris2{at}mailhost.tcs.tulane.edu.
Present address: Department of Neurology, Harvard Medical School,
The Children's Hospital, Boston, MA 02115.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|